Emmett, L., Kwan, E. M., Joshua, A. M., Sharma, S., Hioki, T., Sandhu, S., Crumbaker, M. (2026). Dose optimisation and PSMA receptor intensification with
                    <sup>177</sup>
                    Lu-PSMA-597 in metastatic castration-resistant prostate cancer (mCRPC): The randomised phase II OPTIMAL-PSMA trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps293